Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Maria Jose
Maria Jose Bermejo Oses, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100035781 | Composition which Contains a Mixture of Mono-, Di and Triglycerides and Glycerine - The present invention relates to a composition which contains a mixture of alkoxylated mono-, di-, and triglycerides and glycerine of formula wherein R′ represents H or CH3, and each one of m, n, or l represents, independently, a number from 0 to 20, the sum of m, n, and l being in the range of 1.5 to 20, characterized in that in the acyl group represented by —CO—R, R represents an alkyl or alkenyl group, linear or branched, of 6 to 11 carbon atoms, and the proportion by weight (i)+(ii)+(iii)/(iv) is in the range of 2.0:0.5 to 0.5:3; and to a method for the preparation of said composition, the detergent compositions which contain said compositions, and the use of said composition as surfactant or co-surfactant in the detergent compositions, particularly in detergent compositions, especially, but not exclusively, suitable for washing fabrics, suitable for manual dishwashing, for washing the hair or for personal hygiene. | 02-11-2010 |
| 20100041576 | Detergent Composition - The present invention relates to an aqueous detergent composition comprising the following elements in the indicated amounts expressed as percentage by weight: a) 0.1-15% of at least one alkyl ether carboxylate of formula (I): R—O—(CH | 02-18-2010 |
| 20100331231 | NON-RINSE FABRIC SOFTENER - The invention relates to compositions which are suitable as fabric softeners, particularly for softening fabrics that have been washed with highly concentrated detergents. Said compositions are obtainable by esterification of a C | 12-30-2010 |
Maria Jose Campagnole Santos, Belo Horizonte-Mg BR
| Patent application number | Description | Published |
|---|---|---|
| 20080312129 | Use of Mas G-Protein-Coupled Receptor Agonists and Antagonists, as Apoptotic-Activity Modulators for Study, Prevention and Treatment of Diseases - The present invention is characterized by the use of Mas G-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for study, prevention and treatment of diseases. It is further characterized by the use of Mas G-protein-coupled receptor agonist and antagonists for modulation of the apoptotic activity involving alterations in the activity of the protein kinase B/Akt. Another characteristic of the invention is the use of Mas G-protein-coupled receptor agonists and antagonists, including the Ang-(1-7) peptide and its analogues, agonists and antagonists, either peptidic or non-peptidic, as modulators of apoptotic activity for study, prevention and treatment of degenerative diseases of organs and systems, as an auxiliary measure for organs transplantation, treatment with embryonic, non-embryonic stem cells, re-implantation of organs and tissues and other treatments that need temporary or chronic reduction of the apoptotic activity, not limitative. The invention further claims the use of Mas G-protein-coupled receptor agonists and antagonists, including the Angiotensin-(1-7) peptide and its analogues, agonists and antagonists, either peptidic or non-peptidic, formulated with pharmaceutically and pharmacologically acceptable excipients or carriers, as modulators of the apoptotic activity. | 12-18-2008 |
Maria Jose Churruca, Campana AR
| Patent application number | Description | Published |
|---|---|---|
| 20100155250 | SYNTHESIS OF OIL CONTAINING MICROCAPSULES AND THEIR USE IN FUNCTIONAL COMPOSITE COATINGS - Systems and methods for the synthesis of lubricant-containing microcapsules are disclosed. Embodiments of composite nickel and copper coatings containing capsules with liquid lubricating oil cores are also disclosed. In certain embodiments, microcapsules can be incorporated into a metal plating solution to perform composite electrodeposition to obtain self lubricant metallic coatings. In some embodiments, much lower friction coefficient (˜0.8) and far better wear resistance was obtained with the copper/microcapsules composite. | 06-24-2010 |
Maria Jose Guerrero Martinez, Vizcaya ES
| Patent application number | Description | Published |
|---|---|---|
| 20110268747 | STXBP1 AS PSYCHIATRIC BIOMARKER IN MURINE MODEL SYSTEM AND THEIR USES - A non-human transgenic animal having a polynucleotide encoding an STXBP1 polypeptide, which polynucleotide is operably linked to a promoter, wherein said transgenic animal has greater than wild-type expression of the STXBP1 polypeptide in at least one brain region, as well as related vectors, methods of producing transgenic animals, in vitro and in vivo screening methods for potential therapeutic agents, and methods for treating and diagnosing neuropsychiatric illness are disclosed. | 11-03-2011 |
Maria Jose Guillen Navarro, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20110070232 | Combination Therapy with an Antitumor Alkaloid - The present invention relates to combinations of PM00104 with other anticancer drugs, and the use of these combinations in the treatment of cancer. | 03-24-2011 |
Maria Jose Martinez De Lizarduy Romo, Pamplona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100280672 | System for regulating the active power of a wind farm - An active power regulation process and system of a wind farm comprising an array of aerogenerators (AI), a communications network (RS), and a monitoring and control system (ST). The system of the invention comprises: | 11-04-2010 |
Maria Jose Pazos Guldris, Lugo ES
| Patent application number | Description | Published |
|---|---|---|
| 20110065138 | Quantitative Method For Detecting Yessotoxins In Fishery Products On Based On The Activation That The Toxin Produces In Cellular Phosphodiesterases And Therapeutic Use Of This Activation - The present invention relates to a quantitative method for detecting yessotoxins in fishery products based on the activation the toxin produces on cellular phosphodiesterases and the therapeutic use of this activation. The cellular target of yessotoxin (YTX) and its analogs is the activation of phosphodiesterases (PDEs). The PDEs-YTX bond produces a measurable signal. The bond can be quantified by means of an affinity biosensor or by fluorescence. The biosensor detects biomolecular interactions and allows determining the presence of YTX due to its interaction with PDEs. The variations in the degradation rate of the fluorescent derivative anthraniloyl-cAMP are determined by means of plate fluorescence. The rate at which the PDEs degrade this molecule increases in the presence of YTX. YTX inhibits immunological activation of mastocytes in rats and induces a cytotoxic effect in human hepatocarcinoma cells, which implies two therapeutic uses of YTXs as an antiallergic and antitumor compound. | 03-17-2011 |
Maria Jose Perez Puerto, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20090124686 | GSK-3 INHIBITORS - The invention relates to urea derivatives of formula (I) as inhibitors of glycogen synthase kinase 3β, GSK-3, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which GSK-3 is involved, such as Alzheimer's disease or non-insulin dependent diabetes mellitus. | 05-14-2009 |
| 20090192204 | N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS - The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I) for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus. | 07-30-2009 |
| 20090221647 | N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS - The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I), for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus. | 09-03-2009 |
Maria Jose Pretel Sanchez, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20110118253 | 5-METHYL-1-(NAPHTHALEN-2-YL)-1H-PYRAZOLES USEFUL AS SIGMA RECEPTOR INHIBITORS - The invention relates to compounds having the formula (I): | 05-19-2011 |
Maria Jose Ribal Caparros, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100086932 | BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD - The present invention relates to an in vitro non-invasive bladder cancer diagnosis and/or prognosis method based on the detection and quantification in bladder fluids of the gene expression of certain genes and/or combinations thereof acting as genetic markers of said disease. A bladder cancer diagnosis and/or prognosis kit based on the use of a set of probes suitable for the detection and quantification of the expression pattern of said genes is also contemplated. | 04-08-2010 |
Maria Jose Silvino, Franca BR
| Patent application number | Description | Published |
|---|---|---|
| 20110166226 | PROCESS FOR OBTAINING AN EXTRACT RICH IN ROSMARINIC ACID (RA) FROM THE PLANT ORIGANUM VULGARE AND ITS USE FOR THE TREATMENT OF DIABETES - Diabetes consists of a worldwide public health concern that leads to high levels of morbidity and premature mortality and affects millions of people in countries of any level of development. It is estimated that there are more than 150 million people with diabetes in the world, wherein projections from the World Health Organization (WHO) for 2025 such amount may get to 300 million cases. | 07-07-2011 |
Maria Jose Travassos Leandro, Monte Da Caparica PT
| Patent application number | Description | Published |
|---|---|---|
| 20090053784 | EXPRESSION OF AN ACTIVE CARRIER FROM XYLOSE IN GENETICALLY MODIFIED SACCHAROMYCES CEREVISAE - The present invention confers to the ferementative yeast | 02-26-2009 |
Maria José Cofre Gaete, San Pedro De La Paz CL
| Patent application number | Description | Published |
|---|---|---|
| 20100233652 | Buccal Device for Isolating the Operating Field - The invention relates to dental devices for isolating a working area, comprising a substantially concave main piece having two upper ends and a substantially round edge on a lower area of the main piece, the round edge being adaptable to a patient's mouth; a substantially concave lower cover attached to the lower area of the main piece; two removable pieces each attached to each of the two upper ends of the main piece; and two upper covers each attached to each of the two removable pieces, the upper covers each having a protuberance to allow attachment of a rubber dam. Also provided are methods for providing isolation of a working area in a patient's mouth. | 09-16-2010 |
Maria José Dus Santos, Buenos Aires AR
| Patent application number | Description | Published |
|---|---|---|
| 20110061136 | FUSION PROTEIN THAT DIRECTS VACCINE ANTIGENS TO ANTIGEN-PRESENTING CELLS, AND APPLICATIONS THEREOF - Fusion protein with directioning of vaccinal antigens toward antigen-presenting cells and the applications thereof. This invention relates to a gene construct that comprises, operatively bound, at least one nucleotide sequence (A) that encodes a polypeptide with SEQ ID NO: 1, which has a region that recognises the β chain of the class-II DR antigen present on the surface of antigen-presenting cells; and one nucleotide sequence (B) that encodes a vaccinal antigen of interest. Moreover, this invention relates to recombinant vectors useful for the expression of the gene construct of the invention, transgenic cells and plants transformed or transfected with said vectors, fusion proteins encoded by the gene construct of the invention and vaccines that comprise said fusion proteins. | 03-10-2011 |
Maria José Gómara Elena, Vizcaya ES
| Patent application number | Description | Published |
|---|---|---|
| 20100197606 | NON-PROTEOLYSABLE OLIGOPEPTIDES THAT INHIBIT GLYCOPROTEIN GP41 OF THE AIDS VIRUS - The invention relates to non-proteolysable oligopeptides that inhibit glycoprotein 41 of the AIDS virus. More specifically, the invention relates to the identification of oligopeptides, particularly hexapeptides, (D), (L) or mixed, preferably D-hexapeptides, which inhibit the binding of a retrovirus to a target cell, thereby providing novel therapies against infection from the human immunodeficiency virus (HIV). The invention also relates to the use of said D-hexapeptides in the form of single components or complex mixtures as prophylactic or therapeutic agents for retroviral infections, especially human immunodeficiency virus type 1 (HIV-1). | 08-05-2010 |
Maria José Negro Álvarez, Madrid SE
| Patent application number | Description | Published |
|---|---|---|
| 20100151550 | METHOD FOR RECOVERING ENERGY FROM THE ORGANIC FRACTION OF SOLID URBAN WASTE AND ASSOCIATED FACILITY - The invention relates to a method for recovering energy from the organic fraction of urban solid waste comprising the following steps: a) the organic fraction is pre treated with mineral acids, preferably sulfuric acid, during which the fraction is heated by an outer thermal jacket with no steam injection or steam explosion, thereby producing a first slurry containing an insoluble solid susceptible to enzymatic attack by cellulases; b) a step comprising enzymatic hydrolysis using cellulases and simultaneous fermentation, using an ethanologenic microorganism, of the first slurry in order to obtain a second slurry containing diluted ethanol; and c) distillation of the second slurry such as to obtain wet ethanol, a recyclable liquid effluent and a solid. | 06-17-2010 |
Maria José Rueda Lopez, Las Palmas ES
| Patent application number | Description | Published |
|---|---|---|
| 20090318040 | BUOYAGE AND ENVIRONMENTAL MONITORING INSTRUMENT FOR USE ON REGATTA COURSES, COMPRISING AN INFLATABLE PNEUMATIC PLATFORM AND A MODULAR MAST WHICH CAN BE FOLDED AND TRANSPORTED IN A REDUCED-SIZE COMPACT PACKING CONTAINER - The present invention relates to an instrument for marking and environmental monitoring in regatta courses. Incorporated by inflatable pneumatic platform and modular mast, foldable and transportable in compact packing of reduced size. It is intended to simultaneously define the area of conducting such nautical trials, at the same time as the environmental conditions thereof are characterized, in both meteorological and oceanographic terms. The system comprises an inflatable pneumatic float ( | 12-24-2009 |
María José Bermejo Osés, Barberà Del Vallès-Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20090269294 | Fragrance Precursor - The invention relates to a compound of the following formula (I) X—CR | 10-29-2009 |
María José Castello Llopis, Valencia ES
| Patent application number | Description | Published |
|---|---|---|
| 20100242133 | MANIPULATION OF THE FUNCTION OF AtDBP1 IN ORDER TO GENERATE POTYVIRUS RESISTANCE - The invention relates to the use of a mutation for the generation of virus-resistant mutant plants and, specifically, to the use of mutation 8.1 of the AtDBP1 gene of | 09-23-2010 |
María José DÍaz CabaÑas, Valencia ES
| Patent application number | Description | Published |
|---|---|---|
| 20080267860 | Crystalline Microporous Material Of Zeolitic Nature - A crystalline microporous material of zeolitic nature (ITQ-41) having in its calcined form a chemical composition represented by the empirical formula: | 10-30-2008 |
| 20090124484 | Microporous Crystalline Material, Zeolite ITQ-33, Method of Preparation and Use - The invention relates to a microporous crystalline material which is characterised in that it has the following chemical composition in the calcined state: X | 05-14-2009 |
| 20090220661 | MICROPOROUS CRYSTALLINE MATERIAL, ZEOLITE ITQ-37, PREPARATION METHOD AND USE - The present invention relates to a microporous crystalline material characterized in that it has the following chemical composition in the calcined from: | 09-03-2009 |
| 20100025299 | Catalyst based on solid microporous crystalline material and method of improving diesel fraction quality using said catalyst - The invention relates to a catalyst consisting of at least: one matrix comprising at least one oxide which is selected from an amorphous oxide, an oxide with low crystallinity and a mixture of both; at least one solid microporous crystalline material which, in the calcined and anhydrous state, has the molar compositions X | 02-04-2010 |
María José Gil Morrio, Valencia ES
| Patent application number | Description | Published |
|---|---|---|
| 20090106858 | Isolation and Characterization of the Csb3-1 Mutant of Arabidopsis Thaliana and Use Thereof as a Regulator of Resistance in Plants to Diseases Caused by Biotrophic Pathogens - The invention relates to the technical field of plant biotechnology and, more specifically, to the identification and characterization of the csb3-1 mutant of | 04-23-2009 |
| 20100115668 | Ocp3 gene of arabidopsis thaliana and the ocp3 recessive mutation thereof, and the use of same as a resistance regulator in plants with disease caused by necrotrophic fungal pathogens - The invention relates to the technical field of plant biotechnology and, more specifically, to the OCP3 gene of | 05-06-2010 |